trending Market Intelligence /marketintelligence/en/news-insights/trending/X7Do18B95_GC8wR8bTwTXg2 content esgSubNav
In This List

Cochlear gets US FDA approval for Osia 2 ear implant

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Cochlear gets US FDA approval for Osia 2 ear implant

Australia's Cochlear Ltd. said the U.S. Food and Drug Administration approved its Osia 2 System, an implantable hearing solution that uses wireless technology.

The healthcare equipment company expects to make the device commercially available for patients in the U.S. in early 2020.

The FDA also approved Cochlear's Nucleus Profile Plus series ear implant in June. The agency classifies cochlear implants as Class III devices, which go through the highest level of regulatory scrutiny.